Compound Information | SONAR Target prediction | Name: | 3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradeca hydro-1H-cyclopenta[a]phenanthren-17-one | Unique Identifier: | JFD 01755 | MolClass: | Checkout models in ver1.5 and ver1.0 | Molecular Formula: | C19H28O2 | Molecular Weight: | 262.218 g/mol | X log p: | 1.074 (online calculus) | Lipinksi Failures | 0 | TPSA | 17.07 | Hydrogen Bond Donor Count: | 0 | Hydrogen Bond Acceptors Count: | 2 | Rotatable Bond Count: | 0 | Canonical Smiles: | CC12CCC3C(CC=C4CC(O)CCC34C)C1CCC2=O | Generic_name: | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | Chemical_iupac_name: | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | Drug_type: | Experimental | Drugbank_id: | EXPT00519 | Logp: | 3.73 | Drug_category: | Isomerase inhibitor | Organisms_affected: | -1 |
Species: |
4932 |
Condition: |
pdryCG200 |
Replicates: |
2 |
Raw OD Value: r im |
0.2910±0.0282843 |
Normalized OD Score: sc h |
0.3703±0.0142006 |
Z-Score: |
-28.5863±1.4993 |
p-Value: |
0 |
Z-Factor: |
0.825764 |
Fitness Defect: |
INF |
Bioactivity Statement: |
Active |
Experimental Conditions | | Library: | Bioactive | Plate Number and Position: | 4|C4 | Drug Concentration: | 50.00 nM | OD Absorbance: | 595 nm | Robot Temperature: | 30.00 Celcius | Date: | 2010-08-10 YYYY-MM-DD | Plate CH Control (+): | 0.097±0.01141 | Plate DMSO Control (-): | 1.0005±0.02251 | Plate Z-Factor: | 0.8948 |
| png ps pdf |
6973641 |
1-[(3R,8R,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cycl openta[a]phenanthren-17-yl]ethanone |
6973642 |
1-[(3R,8R,9S,10R,13R,14R,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cycl openta[a]phenanthren-17-yl]ethanone |
6979098 |
1-[(3S,8R,9R,10R,13S,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cycl openta[a]phenanthren-17-yl]ethanone |
6981579 |
n/a |
6983807 |
n/a |
6983808 |
n/a |
internal high similarity DBLink | Rows returned: 3 | |
active | Cluster 10893 | Additional Members: 6 | Rows returned: 1 | |
|